Tara Smith

618 total citations
24 papers, 490 citations indexed

About

Tara Smith is a scholar working on Molecular Biology, Physiology and Clinical Biochemistry. According to data from OpenAlex, Tara Smith has authored 24 papers receiving a total of 490 indexed citations (citations by other indexed papers that have themselves been cited), including 16 papers in Molecular Biology, 4 papers in Physiology and 3 papers in Clinical Biochemistry. Recurrent topics in Tara Smith's work include Peroxisome Proliferator-Activated Receptors (10 papers), Metabolism and Genetic Disorders (3 papers) and Adipose Tissue and Metabolism (3 papers). Tara Smith is often cited by papers focused on Peroxisome Proliferator-Activated Receptors (10 papers), Metabolism and Genetic Disorders (3 papers) and Adipose Tissue and Metabolism (3 papers). Tara Smith collaborates with scholars based in United States, Canada and Japan. Tara Smith's co-authors include David M. Steinhorn, Bradley P. Fuhrman, Kuldip Thusu, Paul L. Wood, P Dandona, Dayan B. Goodenowe, Adil J. Nazarali, Scott Lozanoff, Shawn Ritchie and Dushmanthi Jayasinghe and has published in prestigious journals such as PLoS ONE, Brain Research and Journal of Neurochemistry.

In The Last Decade

Tara Smith

22 papers receiving 456 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Tara Smith United States 13 246 136 91 71 68 24 490
Seiko Oda Japan 10 165 0.7× 56 0.4× 67 0.7× 59 0.8× 28 0.4× 13 564
Clark Undem United States 11 202 0.8× 246 1.8× 211 2.3× 64 0.9× 59 0.9× 16 546
Burcin Özüyaman Germany 7 135 0.5× 38 0.3× 112 1.2× 31 0.4× 64 0.9× 8 562
Satoshi Takabuchi Japan 11 189 0.8× 63 0.5× 84 0.9× 72 1.0× 32 0.5× 17 626
G J Mantych United States 7 166 0.7× 62 0.5× 108 1.2× 28 0.4× 81 1.2× 7 373
Al Haromy Canada 8 249 1.0× 285 2.1× 203 2.2× 57 0.8× 84 1.2× 8 668
J E Barker United States 9 236 1.0× 67 0.5× 253 2.8× 61 0.9× 53 0.8× 15 501
Akiko Miyai Japan 10 276 1.1× 36 0.3× 68 0.7× 24 0.3× 70 1.0× 17 465
Tanneale Marshall Australia 8 177 0.7× 32 0.2× 99 1.1× 42 0.6× 51 0.8× 8 503

Countries citing papers authored by Tara Smith

Since Specialization
Citations

This map shows the geographic impact of Tara Smith's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Tara Smith with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Tara Smith more than expected).

Fields of papers citing papers by Tara Smith

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Tara Smith. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Tara Smith. The network helps show where Tara Smith may publish in the future.

Co-authorship network of co-authors of Tara Smith

This figure shows the co-authorship network connecting the top 25 collaborators of Tara Smith. A scholar is included among the top collaborators of Tara Smith based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Tara Smith. Tara Smith is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Smith, Tara, et al.. (2025). First‐In‐Human Safety, Tolerability, and Pharmacokinetics of PPI‐1011, a Synthetic Plasmalogen Precursor. Clinical and Translational Science. 18(3). e70195–e70195. 1 indexed citations
2.
Smith, Tara, et al.. (2024). A novel inducible animal model for studying chronic plasmalogen deficiency associated with Alzheimer’s disease. Brain Research. 1843. 149132–149132. 2 indexed citations
3.
Smith, Tara, et al.. (2022). Pharmacokinetics, Mass Balance, Excretion, and Tissue Distribution of Plasmalogen Precursor PPI-1011. Frontiers in Cell and Developmental Biology. 10. 867138–867138. 6 indexed citations
4.
Smith, Tara, et al.. (2021). Genetic epidemiology approach to estimating birth incidence and current disease prevalence for rhizomelic chondrodysplasia punctata. Orphanet Journal of Rare Diseases. 16(1). 300–300. 7 indexed citations
5.
Smith, Tara, Jérôme Lamontagne‐Proulx, Mélanie Bourque, et al.. (2019). Neuroprotection and immunomodulation in the gut of parkinsonian mice with a plasmalogen precursor. Brain Research. 1725. 146460–146460. 14 indexed citations
6.
Kulyk, William M., et al.. (2017). Six2 Plays an Intrinsic Role in Regulating Proliferation of Mesenchymal Cells in the Developing Palate. Frontiers in Physiology. 8. 955–955. 14 indexed citations
7.
Bourque, Mélanie, Marc Morissette, Tara Smith, et al.. (2017). Plasmalogen precursor mitigates striatal dopamine loss in MPTP mice. Brain Research. 1674. 70–76. 14 indexed citations
8.
Bourque, Mélanie, Marc Morissette, Tara Smith, et al.. (2016). Plasmalogen Augmentation Reverses Striatal Dopamine Loss in MPTP Mice. PLoS ONE. 11(3). e0151020–e0151020. 42 indexed citations
9.
Kharas, Gregory B., et al.. (2016). Novel copolymers of styrene. 3. Some ring-substituted propyl 2-cyano-3-phenyl-2-propenoates. Journal of Macromolecular Science Part A. 53(10). 605–609.
10.
Grégoire, Laurent, et al.. (2015). Plasmalogen precursor analog treatment reduces levodopa-induced dyskinesias in parkinsonian monkeys. Behavioural Brain Research. 286. 328–337. 24 indexed citations
11.
12.
Smith, Tara, et al.. (2013). Molecular signaling along the anterior–posterior axis of early palate development. Frontiers in Physiology. 3. 488–488. 50 indexed citations
13.
Wood, Paul L., Tara Smith, Wei Jin, et al.. (2011). In vitro and in vivo plasmalogen replacement evaluations in rhizomelic chrondrodysplasia punctata and Pelizaeus-Merzbacher disease using PPI-1011, an ether lipid plasmalogen precursor. Lipids in Health and Disease. 10(1). 182–182. 29 indexed citations
14.
Wood, Paul L., et al.. (2011). Oral bioavailability of the ether lipid plasmalogen precursor, PPI-1011, in the rabbit: a new therapeutic strategy for Alzheimer's disease. Lipids in Health and Disease. 10(1). 227–227. 32 indexed citations
15.
Wood, Paul L., et al.. (2011). Targeted metabolomic analyses of cellular models of pelizaeus-merzbacher disease reveal plasmalogen and myo-inositol solute carrier dysfunction. Lipids in Health and Disease. 10(1). 102–102. 19 indexed citations
16.
Smith, Tara, M. Saïd Ghandour, & Paul L. Wood. (2011). Detection ofN‐acetyl methionine in human and murine brain and neuronal and glial derived cell lines. Journal of Neurochemistry. 118(2). 187–194. 25 indexed citations
17.
Wood, Paul L., Mohd Sajid Khan, Tara Smith, & Dayan B. Goodenowe. (2011). Cellular diamine levels in cancer chemoprevention: modulation by ibuprofen and membrane plasmalogens. Lipids in Health and Disease. 10(1). 214–214. 12 indexed citations
18.
Smith, Tara, Xia Wang, Wei Zhang, William M. Kulyk, & Adil J. Nazarali. (2009). Hoxa2 plays a direct role in murine palate development. Developmental Dynamics. 238(9). 2364–2373. 12 indexed citations
19.
Smith, Tara, David M. Steinhorn, Kuldip Thusu, Bradley P. Fuhrman, & P Dandona. (1995). A liquid perfluorochemical decreases the in vitro production of reactive oxygen species by alveolar macrophages. Critical Care Medicine. 23(9). 1533–1539. 124 indexed citations
20.
Smith, Tara, David M. Steinhorn, Kenda Marcucci, et al.. (1994). PERFLUBRON (PFB) DECREASES FREE RADICAL (FR) PRODUCTION BY ALVEOLAR MACROPHAGES (AM) IN VITRO. Critical Care Medicine. 22(1). A196–A196. 8 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Seiko Oda Breakdown of academic impact, for papers by Clark Undem Breakdown of academic impact, for papers by Burcin Özüyaman Breakdown of academic impact, for papers by Satoshi Takabuchi Breakdown of academic impact, for papers by G J Mantych Breakdown of academic impact, for papers by Al Haromy Breakdown of academic impact, for papers by J E Barker Breakdown of academic impact, for papers by Akiko Miyai Breakdown of academic impact, for papers by Tanneale Marshall
Rankless by CCL
2026